$AGN Company News Actavis expects profit to beat

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$AGN Company News

Actavis expects profit to beat expectations 9:44 a.m. Jan. 12, 2015 - Michael Calia
Drug trials, upgrades boost health-care sector 11:57 a.m. Jan. 8, 2015 - Russ Britt
Linn Energy jumps as Tesla, Apple fall 2:30 p.m. Jan. 2, 2015 - Wallace Witkowski
Eight charts plot the year in finance 12:45 p.m. Dec. 30, 2014 - Ophir Gottlieb
Here are the best S&P 500 stocks and sectors of 2014 1:52 p.m. Dec. 29, 2014 - Philip van Doorn
2014 was the year that all predictions were wrong 11:29 a.m. Dec. 26, 2014 - Marek Fuchs
What a week: Botox haze, merger Monday and The Tanned One 9:19 a.m. Nov. 21, 2014 - Marek Fuchs
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Nov. 20, 2014 - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore


What to Expect When Allergan (AGN) Reports Fourth-Quarter Earnings Tomorrow 3:38 p.m. Feb. 2, 2015 - TheStreet.com
Will Allergan (AGN) Disappoint on Earnings This Quarter? - Analyst Blog 3:20 p.m. Feb. 2, 2015 - Zacks.com
Revenge of the Giants in Stock Picks 5:03 a.m. Jan. 31, 2015 - Barrons.com
Judge Clears Way for Dendreon to Auction Provenge 2:32 p.m. Jan. 30, 2015 - The Wall Street Journal Interactive Edition
Valeant in Deal to Buy Provenge From Dendreon 10:39 p.m. Jan. 29, 2015 - The Wall Street Journal Interactive Edition
Sientra: A Breast Implant Pure-Play With A Technologically Superior Implant, Initiating Bullish 3:43 p.m. Jan. 29, 2015 - Seeking Alpha
Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog 11:23 a.m. Jan. 29, 2015 - Zacks.com
Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog 8:27 a.m. Jan. 29, 2015 - Zacks.com
Actavis to Buy Auden Mckenzie, Boost Generic Portfolio - Analyst Blog 6:00 p.m. Jan. 27, 2015 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 12:07 p.m. Jan. 27, 2015 - TheStreet.com
A Radical Idea for Activist Investors 9:51 a.m. Jan. 27, 2015 - The Wall Street Journal Interactive Edition
Actavis to Buy Auden Mckenzie 8:15 a.m. Jan. 26, 2015 - The Wall Street Journal Interactive Edition
A Look At Actavis 2:31 p.m. Jan. 22, 2015 - Seeking Alpha
Trade-Ideas: Allergan (AGN) Is Today's New Lifetime High Stock 9:45 a.m. Jan. 22, 2015 - TheStreet.com
Jim Cramer Sees Actavis Shares Going Higher, Possibly to $320 11:40 a.m. Jan. 21, 2015 - TheStreet.com
The One Fund You Should Own in Your 401k 6:35 a.m. Jan. 21, 2015 - InvestorPlace.com
Salix Pharma Reportedly Exploring Sale; Stock Up 2:06 p.m. Jan. 20, 2015 - Investors Business Daily
Ackman Brings Veteran M&A Lawyer on Board 12:05 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
New Activist Hedge Fund Has CEO Backing 12:00 a.m. Jan. 20, 2015 - The Wall Street Journal Interactive Edition
Roche to Acquire French Biotechnology Company Trophos - Analyst Blog 6:10 p.m. Jan. 19, 2015 - Zacks.com


Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 7:01 p.m. Jan. 30, 2015 - PR Newswire - PRF
Global Pediatric Drugs and Vaccines Market 11:56 a.m. Jan. 27, 2015 - PR Newswire - PRF
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - BusinessWire - BZX
Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC 5:30 p.m. Jan. 26, 2015 - PR Newswire - PRF
Lieff Cabraser Announces Class Action Litigation Against Allergan Inc. - AGN 2:21 a.m. Jan. 23, 2015 - BusinessWire - BZX
UPDATE - AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:22 p.m. Jan. 20, 2015 - GlobeNewswire
Pre-Market Pulse on Pharma Stocks - Teva Pharma Industries, Allergan, Endo Intl., Akorn, and Depomed 8:30 a.m. Jan. 16, 2015 - PR Newswire - PRF
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis’ Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:02 a.m. Jan. 12, 2015 - BusinessWire - BZX
Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings 8:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
ALERT: Rosen Law Firm Reminds Investors Who Sold Allergan Inc. Stock of the Important Class Action Deadline -- AGN 11:11 a.m. Jan. 6, 2015 - GlobeNewswire
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 10:32 a.m. Dec. 29, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investors Who Sold Allergan, Inc. Common Stock Between February 25, 2014 and April 21, 2014 Are Encouraged to Contact Glancy Binkow & Goldberg LLP 12:32 p.m. Dec. 23, 2014 - BusinessWire - BZX
AGN SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Involving Allergan, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 16, 2015 -- AGN 5:48 p.m. Dec. 18, 2014 - GlobeNewswire
EQUITY ALERT: The Rosen Law Firm Announces the Filing of Securities Class Action on Behalf of Sellers of Allergan Inc. Stock From February 25, 2014 to April 21, 2014 Seeking to Recover Losses -- AGN 3:59 p.m. Dec. 18, 2014 - GlobeNewswire
COTCHETT, PITRE & McCARTHY, LLP Files Class Action Lawsuit on Behalf of Persons Who Sold Allergan Stock Between February 25, 2014 and April 21, 2014 1:47 p.m. Dec. 17, 2014 - BusinessWire - BZX
Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Shares Announced by Shareholders Foundation 11:15 a.m. Dec. 17, 2014 - GlobeNewswire
BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Persons Who Sold Allergan Stock Between February 25, 2014 And April 21, 2014 9:30 a.m. Dec. 17, 2014 - PR Newswire - PRF
Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers Squibb, Teva Pharmaceutical Industries, Endo Intl., and Allergan 9:05 a.m. Dec. 17, 2014 - PR Newswire - PRF
Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition 7:30 a.m. Dec. 16, 2014 - PR Newswire - PRF
Wilshire Confirms First-to-File Patent Challenge Relating to LASTACAFT® 3:18 p.m. Dec. 11, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 210

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 0

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 244

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 55

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
HONOR Leads in China, Eyes Middle East Market

Updated Category News Views 23

A Force to be Reckoned With Talk about making waves—HONOR's got the bragging rights now. Sitting pretty at the top among Android smartphone brands in China ain't no small feat. We're looking at a snazzy 12.04% market share for October 2026, all thanks to selling a cool 2.573 million units. The kicker? This ain't even their full potential. They're hustling hard in the...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 328

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 37

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 0

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
a>